Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Anca Mera"'
Autor:
Patriek Jurrius, Thomas Green, Hans Garmo, Matthew Young, Massimiliano Cariati, Cheryl Gillett, Anca Mera, Mark Harries, Anita Grigoriadis, Sarah Pinder, Lars Holmberg, Arnie Purushotham
Publikováno v:
Breast, Vol 50, Iss , Pp 39-48 (2020)
Background: Major advances in breast cancer treatment have led to a reducuction in mortality. However, there are still women who are not cured. We hypothesize there is a sub-group of women with treatment-resistant cancers causing early death. Methods
Externí odkaz:
https://doaj.org/article/547d78fbf48c4294986e80fd5ffec387
Autor:
Christos Petridis, Iteeka Arora, Vandna Shah, Anargyros Megalios, Charlotte Moss, Anca Mera, Angela Clifford, Cheryl Gillett, Sarah E. Pinder, Ian Tomlinson, Rebecca Roylance, Michael A. Simpson, Elinor J. Sawyer
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Introduction Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal breast cancer, and approximately 20% of screen-detected tumours are pure DCIS. Most risk factors for breast cancer have similar associations with DCI
Externí odkaz:
https://doaj.org/article/29c815eb10694984857d134f799ad0d8
Autor:
Beth Russell, Charlotte Moss, Eirini Tsotra, Charalampos Gousis, Debra Josephs, Deborah Enting, Christina Karampera, Muhammad Khan, Jose Roca, Ailsa Sita-Lumsden, Kasia Owczarczyk, Harriet Wylie, Anna Haire, Daniel Smith, Kamarul Zaki, Angela Swampillai, Mary Lei, Vishal Manik, Vasiliki Michalarea, Rebecca Kristeleit, Anca Mera, Elinor Sawyer, Lucy Flanders, Irene De Francesco, Sophie Papa, Paul Ross, James Spicer, Bill Dann, Vikash Jogia, Nisha Shaunak, Hartmut Kristeleit, Anne Rigg, Ana Montes, Mieke Van Hemelrijck, Saoirse Dolly
Publikováno v:
Cancers, Vol 14, Iss 2, p 266 (2022)
Background: This study aimed to assess the outcome of cancer patients undergoing systemic anti-cancer treatment (SACT) at our centre to help inform future clinical decision-making around SACT during the COVID-19 pandemic. Methods: Patients receiving
Externí odkaz:
https://doaj.org/article/828cc925c5fb4f8ab9dc5a32eebce9bb
Autor:
Katherine Lawler, Efterpi Papouli, Cristina Naceur-Lombardelli, Anca Mera, Kayleigh Ougham, Andrew Tutt, Siker Kimbung, Ingrid Hedenfalk, Jun Zhan, Hongquan Zhang, Richard Buus, Mitch Dowsett, Tony Ng, Sarah E. Pinder, Peter Parker, Lars Holmberg, Cheryl E. Gillett, Anita Grigoriadis, Arnie Purushotham
Publikováno v:
Breast Cancer Research, Vol 19, Iss 1, Pp 1-15 (2017)
Abstract Background Metastases from primary breast cancers can involve single or multiple organs at metastatic disease diagnosis. Molecular risk factors for particular patterns of metastastic spread in a clinical population are limited. Methods A cas
Externí odkaz:
https://doaj.org/article/03ebc95b8b9b486a9ced3d7038773c8f
Autor:
Jasmine Timbres, Charlotte Moss, Anca Mera, Anna Haire, Cheryl Gillett, Mieke Van Hemelrijck, Elinor Sawyer
Publikováno v:
Cancers, Vol 13, Iss 12, p 3036 (2021)
Invasive lobular breast cancer (ILC) accounts for 10–15% of breast cancers and has distinct characteristics compared with the more common invasive ductal carcinoma (IDC). Studies have shown that ILC may be less sensitive to chemotherapy than IDC, w
Externí odkaz:
https://doaj.org/article/c59ebe4a14054a999f33ecb9b4d1574e
Autor:
Chee Chee Tang, Jasmine Timbres, Kelvin Ramsey, Anca Mera, Sheeba Irshad, Elinor Sawyer, Aadil Khan
Publikováno v:
Cancer Research. 83:P6-03
Clinico-pathological co-variates define a predictive model of breast cancer related lymphoedema (BCRL) in patients undergoing axillary surgery for breast cancer CC Tang1*, J Timbres2*, KWD Ramsey1, A Mera2, S Irshad2, E Sawyer2, AA Khan1 1 Department
Autor:
Charlotte Moss, Cheryl Gillett, Anna Haire, Jasmine Timbres, Anca Mera, Mieke Van Hemelrijck, Elinor J. Sawyer
Publikováno v:
Cancers
Volume 13
Issue 12
Cancers, Vol 13, Iss 3036, p 3036 (2021)
Volume 13
Issue 12
Cancers, Vol 13, Iss 3036, p 3036 (2021)
Simple Summary Around 10–15% of breast cancer diagnoses are invasive lobular cancers (ILC), and they are currently treated in a similar way to the more common invasive ductal cancer (IDC), although they display different characteristics. The main o
Autor:
Sarah E Pinder, Christos Petridis, Elinor J. Sawyer, Anca Mera, Vandna Shah, Michael A. Simpson, Ian Tomlinson, Angela Clifford, Iteeka Arora, Cheryl Gillett, Rebecca Roylance, Charlotte Moss
Publikováno v:
Petridis, C, Arora, I, Shah, V, Moss, C L, Mera, A, Clifford, A, Gillett, C, Pinder, S E, Tomlinson, I, Roylance, R, Simpson, M A & Sawyer, E J 2019, ' Frequency of pathogenic germline variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1 and TP53 in sporadic lobular breast cancer ', Cancer Epidemiology Biomarkers and Prevention, vol. 28, no. 7, pp. 1162-1168 . https://doi.org/10.1158/1055-9965.EPI-18-1102
Background: Invasive lobular breast cancer (ILC) accounts for approximately 15% of invasive breast carcinomas and is commonly associated with lobular carcinoma in situ (LCIS). Both have been shown to have higher familial risks than the more common du
Autor:
Matthew Young, Thomas Green, Anita Grigoriadis, Arnie Purushotham, Sarah E Pinder, Lars Holmberg, Massimiliano Cariati, Cheryl Gillett, Patriek Jurrius, Mark Harries, Anca Mera, Hans Garmo
Publikováno v:
The Breast : official journal of the European Society of Mastology
Breast, Vol 50, Iss, Pp 39-48 (2020)
Breast, Vol 50, Iss, Pp 39-48 (2020)
Background Major advances in breast cancer treatment have led to a reducuction in mortality. However, there are still women who are not cured. We hypothesize there is a sub-group of women with treatment-resistant cancers causing early death. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154f9752adee0b97372be27c9a82285f
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-408530
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-408530
Autor:
V Michalarea, Anca Mera, I Sandri, Mhr Chowdhury, Janine Mansi, Kiruthikah Thillai, E. Karapanagiotou, A. Lucey
Publikováno v:
Cancer Research. 77:P3-17
Background Ductal Carcinoma in Situ (DCIS) plays a pivotal role in surgical planning for patients who are to undertake primary chemotherapy. As DCIS is not thought to be responsive to chemotherapy, many women with large primaries or extensive DCIS on